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Abstract
Embryonic stem (ES) cells can differentiate in vitro into a variety of cell types. Efforts to produce endodermal cell derivatives,
including lung, liver and pancreas, have been met with modest success. Understanding how the endoderm originates from
ES cells is the first step to generate specific cell types for therapeutic purposes. Recently, it has been demonstrated that
inhibition of Myc or mTOR induces endodermal differentiation. Both Myc and mTOR are known to be activators of the
Pentose Phosphate Pathway (PPP). We found that, differentely from wild type (wt), ES cells unable to produce pentose
sugars through PPP differentiate into endodermal precursors in cell culture conditions generally non-permissive to generate
them. The same effect was observed when wt ES cells were differentiated in presence of chemical inhibitors of the PPP.
These data highlight a new role for metabolism. Indeed, to our knowledge, it is the first time that modulation of a metabolic
pathway is described to be crucial in determining ES cell fate.
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Introduction
Endoderm-derived organ diseases include cystic fibrosis, chronic
hepatitis, and diabetes; they affect more than 150 million people
worldwide. Existing transplantation-based therapies are currently
limited by the availability of donor-derived tissues.
Embryonic stem (ES) cells have the potential to give rise to any of
the hundreds of cell types in the human body, raising exciting new
prospects for biomedical research and for regenerative medicine [1].
Indeed, ES cells are a promising, renewable source of material for
transplantation, because they can be expanded indefinitely in culture
and can differentiate into all cell types of the body. Researchers are
now taking advantage of the understanding of endoderm organo-
genesis to successfully direct the differentiation of ES cells into
pancreas, liver, lung and thyroid cells [2]. The potential to virtually
generate any differentiated cell typefrom EScells offersthe possibility
to establish new models of mammalian development and to create
new sources of cells for regenerative medicine. To realize this
potential, it is essential to be able to control ES cells differentiation
and to direct the development of these cells along specific pathways
[1]. The molecular events regulating the induction and tissue-specific
differentiation of endoderm are central to our understanding of the
development and function of many organ systems [3].
Myc transcription factor and mTOR (Mammalian Target of
Rapamycin) are both key regulators of cell growth and
proliferation, and both have been described to control ES cells
fate. In particular, Myc and mTOR repress endoderm differen-
tiation of ES cells [4], [5]. Furthermore, both mTOR and Myc
regulate the Pentose Phosphate Pathway (PPP). Indeed, it has been
described that mTOR complex 1 activation leads to induction of
genes encoding the enzymes of the PPP [6] and cMyc induces the
production of ribose sugars, the product of the PPP [7].
We have generated mouse ES cells with a G6pd gene deletion
(G6pdD). G6PD is the first and key enzyme of the PPP that, oxidizing
glucose-6-phosphate, produces NADPH and pentose sugars. We
have previously shown that these cells are extremely sensitive to
oxidative stress, in keeping with the notion that G6PD is essential for
production of high levels of NADPH, required for detoxification of
reactive oxygen species [8], [9], [10], [11]. In addition, it has been
reported that severe G6PD deficiency is lethal for mouse embryo.
Severely G6PD-deficient hemizygous male embryos stop growing
between E7.5 to E8.5 and show severe abnormalities, indicating that
the role of G6PD is quite basic in mammalian development [12].
In this report we show, using engineered ES cells, that
modulation of the PPP is necessary to drive ES cells differentiation
into endodermal precursor cells. The data were confirmed in wt
ES cells using two chemical inhibitors of the PPP. Moreover, we
show that the mechanism does not involve the role of the PPP in
providing reducing equivalent but rather its function in the
production of pentose sugars.
Results
Analysis of gene expression during wt and G6pdD ES
cells differentiation
We differentiated wt and G6pdD ES cells, using the previously
described protocol to differentiate ES into neuronal cells [13], and
analyzed the expression profiles of undifferentiated cells and three
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of differentiation the expression of Oct4 and Nanog, markers of
undifferentiated ES cells, are undetectable in both cell lines
(Figure 1A). Moreover, no differences in the expression profile of
Nestin (neuronal precursor marker), NF-L (marker of neurons),
GFAP (glial cell marker), and Nkx2.5 were observed between wt
and G6pdD ES cells (Figure 1A); aMHC (cardiomyocyte specific
marker) and TDO (hepatocyte specific marker) were not expressed
in both cell lines (data not shown). Instead, whereas endoderm was
never formed during wt ES differentiation, from day 8 of
differentiation in G6pdD ES cells we observed the expression of
GATA4 (mesendodermal marker) and Sox17 (endodermal
precursor marker) (Figure 1A). The expression of Sox17 was
confirmed by immunofluorescence analysis on wt and G6pdD ES
cells at 10 days of differentiation using anti-Sox17 antibody
(Figure 1B). Since GATA4 was previously seen expressed in
neurons and astrocytes [14], we analyzed, by immunofluores-
cence, the co-expression of GATA4 with bIII-tubulin (neural
marker) or GFAP and we never observed co-expression of these
markers (Figure S1A, B). Sox17 has been described to be
expressed also in oligodendrocytes [15]; by western blot, we
analyzed the expression of Olig2 (oligodendrocytes specific
marker), but our cell culture method does not allow the
differentiation of oligodendrocytes (Figure S1C). These data
strengthen our hypothesis that GATA4 and Sox17 are expressed
in endodermal precursors during G6pdD ES cells differentiation.
To verify that the expression of endodermal specific markers
was caused by inactivation of G6pd gene, and not by accidentally
produced abnormalities, we confirmed, after differentiation, the
expression of those markers in two different ES cell lines, G6pdD1
and G6pdD2, carrying the deletion of G6pd gene (Figure 1C).
Moreover, in G6pdD
pG6pd ES cells, G6pdD ES cells transfected with
an expression vector containing a puromycin resistance gene in
which the expression of G6pd is driven by the b-actin promoter
[11], we never observed the expression of GATA4 and Sox17
(Figure 1C) although they differentiate in neuronal cell lines as
proved by the expression of specific neuronal markers.
Nodal signalling participates in the nervous system patterning
but also in mesendoderm induction. Smad2 is an essential
intracellular transducer of the Tgf-b/Nodal signal. Nodal
signalling through type I (ALK4 and ALK7) and type II (ActRIIA
and ActRIIB) receptors in conjunction with its co-receptor, Cripto,
is crucial for generating mesendoderm precursor cells. Following
the engagement of Nodal with its receptor, Smad2 becomes
phosphorylated and induces mesendodermal differentiation [16],
[17], [18]. During differentiation we confirmed that Nodal was
expressed both in wt and G6pdD ES cells although at higher level
in the last one (Figure S1D). We also analyzed Cripto expression in
wt and G6pdD ES cells. Although Cripto is already switched off at
day 4 of differentiation in wt ES cells, its expression is still present
at day 6 of differentiation in G6pdD ES cells (Figure 1D, Figure
S1E). Moreover, we found that Smad2 phosphorylation is induced
in differentiating G6pdD compared to wt until day 6 of
differentiation, although this pathway is active also in wt ES cells
during neuronal differentiation (Figure 1E).
Induction of Definitive and Extraembryonic Endoderm
Sox17 is expressed in definitive endoderm but also in
extraembryonic endoderm. Borowiak et al. (2009) found that
Sox17+ cells can have two distinct morphologies: as dispersed
Sox17+ cells or clustered populations [19]. They demonstrated
that the dispersed Sox17+ cells also expressed extraembryonic
endoderm markers. Positive identification of definitive endoderm
is hindered by lack of unique markers that are expressed
exclusively in these cells. Borowiak et al. (2009) concluded that
clustered populations of Sox17+ cells are definitive endoderm,
indeed these cells do not express extraembryonic markers [19].
Although we used a different protocol to differentiate G6pdD ES
cells, we observed Sox17+ cells with both clustered and dispersed
morphologies (Figure 2A). These data let us hypothesize that both
extraembryonic and definitive endodermal cells could be differ-
entiated from G6pdD ES cells.
To better define whether both cell populations are formed
during G6pdD ES cell differentiation, we confirmed the presence of
extraembryonic marker Sox7 by RT-PCR analysis (Figure 2B)
[20]. Moreover, Chen et al. (2009) identified a small molecule,
Indolactam V, that can induce differentiation of endodermal
precursor cells (Sox17+) into pancreatic progenitor cells [21]. Wt
and G6pdD ES cells at 8 days of differentiation were grown for 5
more days in presence of Indolactam V; the analysis by real-time
RT-PCR (qRT-PCR) of mRNA extracts from both cell lines
revealed the presence of Pdx1, a marker of pancreatic progenitors,
exclusively in G6pdD ES cells (Figure 2C).
The presented data support our hypothesis that both extraem-
bryonic and definitive endoderm Sox17+ cells are induced during
G6pdD ES cells differentiation.
Analysis of the mechanism inducing endodermal cell
differentiation
Redox status mediates ES differentiation [22]. G6PD, a
NADPH-producing dehydrogenase, is an enzyme essential for
the defense of the cells against oxidative stress. To analyze whether
oxidant formed in absence of G6PD have a role in establishing the
mechanism that drives differentiation of G6pdD ES cells into
endodermal cells, we differentiated wt and G6pdD ES cells with the
previously described protocol in presence of a lower oxygen
concentration described to be a physiological oxygen level during
development (normoxia) [23], 5% instead of the 20% used in the
normal culture conditions. Although in these culture conditions a
reduced amount of ROS is formed (Figure S2A), we observed
expression of GATA4 and Sox17 indicating that endodermal
precursor cells are still differentiated (Figure 3A). Moreover,
differentiating ES cells in presence of N-acetylcysteine (NAC), a
well-known antioxidant molecule, G6pdD ES cells are still able to
differentiate into endodermal cells, in fact they expressed GATA4
and Sox17, differently from wt ES cells (Figure S2B).
Being the first and key enzyme of the PPP, G6PD is essential
also for the production of pentose sugars. To analyze whether the
pentose sugars have a role in establishing the differentiation fate of
G6pdD ES cells into endodermal precursors, we differentiated
heterozygous knockout ES cells for Phosphogluconate Dehydro-
genase (Pgd+/2 ES cells), the second enzyme of the PPP, using the
previously described protocol. These cells, compared to wt ES,
have a reduced amount of Pgd mRNA (Figure S3A), a reduced
flow of glucose carbon through the oxidative arm of the PPP
(Figure S3B) and moreover, differently from G6pdD ES cells, they
are not sensitive to oxidative stress (Figure S3C). As previously
observed in G6pdD, also Pgd+/2 ES cells are able to differentiate
into endodermal cells (Figure 3B, C, Figure S3D, E, F). These data
suggest that modulation of the PPP is important to drive
endodermal fate.
Moreover, to confirm the hypothesis that the amount of pentose
sugars present in the cells can influence the differentiation fate, we
differentiated wt and G6pdD ES cells in presence of D-(-)-ribose.
Although the addition of D-(-)-ribose had no effect on wt ES cells
differentiation, we observed a reduction in the amount of Sox17
mRNA in G6pdD differentiated ES cells (Figure 3D), confirming
our hypothesis. We observed the same effect differentiating G6pdD
Pentose Phosphate Pathway and Endoderm
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sugars like L-Arabinose or Sucrose had no effect on Sox17 mRNA
(Figure S3G)
The addition of D-(-)-ribose during differentiation to G6pdD ES
cells had no effect on carbon flow through Glycolysis and citric
acid cycle, Maillard reaction and did not increase the amount of
ROS (data not shown).
Chemical inhibitors of the PPP induce wt ES cells to
differentiate into endodermal cells
DHEA and 6AN have been described to inhibit respectively
G6PD and PGD activity [24], [25]. To confirm that DHEA and
6AN were inhibiting the PPP in ES cells, we measured, in wt ES
cells the flow of glucose carbon through the oxidative arm of the
PPP, at maximum non toxic concentration of both substances
(DHEA and 6AN) and observed a statistically significant reduction
of the pathway (Figure 4A); moreover, to verify that DHEA was
acting on G6PD while 6AN was acting on PGD, we tested the
capability to respond to oxidative stress of treated cells compared
to wt and we observed that, as expected, DHEA treated wt ES
cells were more sensitive to oxidizing agents as G6pdD ES cells
[10], while 6AN treated cells show the same resistance as wt and
Pgd+/2 ES cells (Figure S4B).
Since both chemicals were able to inhibit the PPP in ES cells,
we investigated their effect on wt ES cells differentiation.
Immunofluorescence analysis revealed that both substances are
able to induce differentiation of wt ES cells in Sox17+ cells
(Figure 4A). Moreover, by qRT-PCR we observed an increase in
the amount of GATA4 and Sox17 mRNA in DHEA and 6AN
treated wt ES cells (Figure 4B).
Discussion
Understanding how the endoderm forms from ES cells is the
first step towards the ultimate goal, generating specific cell types
for therapeutic purposes. Studies in Xenopus laevis, zebrafish, and
mice collectively, suggest a conserved mechanism for mesoderm/
endoderm lineage commitment involving the transforming growth
factor-b (TGF b) family member Nodal, and a common set of
downstream effector molecules [16], [17], [26].
One promising differentiation strategy is to recapitulate, in vitro,
the developmental signals that guide cells towards specific lineages
during development [19]. In vitro it has been shown that addition of
Activin A or Nodal during ES cells differentiation leads to
endodermal induction.
Recently, two groups [19], [27] illustrate high throughput
screening to discover novel small molecules able to induce
embryonic stem cell differentiation into definitive endoderm.
However, the molecules reported have still necessity of serum
presence in the differentiation protocols. This means that we are
still not acquainted with all the pathways involved in endodermal
differentiation and, moreover, we still don’t know how to control
them.
The PPP has been described to be essential in the cell during the
defence against oxidative stress. Our results show, for the first time,
that modulation of this metabolic pathway could influence stem
cell differentiation. In fact, we observed that cells unable to
produce pentose sugars through the PPP, under chemically
defined conditions, spontaneously differentiate into endodermal
precursor cells. In the same culture conditions, as we showed
before [13], wt ES cells only differentiate into neuronal cells.
The specification of mesendodermal is postulated to be
dependent on Tgf-b/Nodal pathway [16], [17]. Although Smad2
seems to be active also in wt ES cells, we observed an increased
activation of this pathway in G6pdD ES cells; furthermore,
expression of Cripto, the Nodal co-receptor, was persistent in
G6pdD ES cells until day 6 of differentiation. These data suggest
that mesendodermal differentiation could be dependent on Tgf-b/
Nodal pathway in G6pdD ES cells. Moreover, modulation of the
PPP seems to be required upstream Tgf-b/Nodal pathway
activation during mesendodermal induction.
We showed that the mechanism implicated in this process
involves the role of the PPP in the production of pentose sugars
either than the previously described function in the oxidative stress
defense. Indeed, we observed that reduction of oxidative stress,
during the differentiation process in G6pdD ES cells, did not inhibit
the Sox17 activation. Moreover, Pgd+/2 ES cells, also having a
deficit in the PPP, are able to generate endodermal precursor cells
even if they have a normal resistance to oxidative stress due to the
normal G6PD activity.
In contrast, addition of D-(-)-ribose, a pentose sugar produced
by PPP, to the cell culture differentiation medium decreases the
amount of Sox17 transcript, suggesting that the concentration of
pentose sugars in the cells could be the signal that induces
endodermal differentiation.
Furthermore, we identified two substances, DHEA and 6AN,
known to inhibit the PPP, that act as endodermal inductors.
G6pd is an X-linked gene. In female heterozygous for G6PD
mutation causing severe deficiency, once X inactivation has
produced mosaicism for the G6PD cellular phenotype, there is a
strong selection against G6PD(2) cells both in mouse and in
human [12], [28]. Nevertheless, analysis of G6PD(+/2) hetero-
zygous female showed that, differently from other tissues, intestinal
crypts deriving each from an endodermal stem cell were severely
G6PD deficient [12]. These data confirmed ours, in fact they
suggested that also in vivo in absence of G6PD, cells show the
intrinsic ability to colonize endodermal derived tissues and to
differentiate into endodermal cells.
Pgd has been identified in ES cells as a direct target of Myc in
two different ChIP-on-chip analysis [5], [29]. In a different
experiment, cMyc has been described to induce the production of
the pentose sugar [7]. Recent data has reported that genes of the
Figure 1. Endodermal induction in G6pdD ES cells. (A) Analysis of different markers in wt and G6pdD ES cells during neural differentiation.
Expression profiles of undifferentiated ES cells (Oct4 and Nanog), neural precursors (Nestin), neurons (NF-L), astrocytes (GFAP), mesendodermal
precursors (GATA4), endodermal precursors (Sox17), and cardiac precursors (Nkx2.5) markers were analyzed by RT-PCR. RNA was isolated from cells at
different days of differentiation. Lane C, positive control, RNA isolated from 14dpc embryos. Amplified HPRT is shown as a positive control. (B) Double
immunostaining Sox17/bIII-tubulin/DAPI of cells at 10 days of differentiation showed areas of immunoreactive cells for Sox17 only in G6pdD ES cells.
Scale bars, 50 mm. (C) RT-PCR analysis of GATA4, Sox17, NF-L (neural marker), TH (dopaminergic neuron marker) and GAD65 (gabaergic neuron
marker) on wt, two different G6pdD ES cell lines, and G6pdD
pG6pd during differentiation. Lane C, positive control, on RNA isolated from 14dpc
embryos. Amplified HPRT is shown as a positive control. (D) Western blot analysis with anti-Cripto and anti-Actin antibodies performed on protein
extracts from wt and G6pdD ES cells during neural differentiation. Actin was analyzed as loading control. Below each lane the relative quantities (RQ)
with respect to related undifferentiated embryonic stem cells are indicated. (E) Western blot analysis with anti-phospho-Smad2 and anti-Actin
antibodies performed on protein extracts from wt and G6pdD ES cells during neural differentiation. Actin was analyzed as loading control. Below each
lane the relative quantities (RQ) with respect to related undifferentiated embryonic stem cells are indicated.
doi:10.1371/journal.pone.0029321.g001
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PLoS ONE | www.plosone.org 4 January 2012 | Volume 7 | Issue 1 | e29321Figure 2. Definitive and extraembryonic endoderm differentiated from G6pdD ES cells. (A) Immunofluorescent staining of the
differentiated mouse G6pdD ES cells for Sox17 (red) and nuclei (blue) at 8 days of neural differentiation. PH, phase contrast images. Scale bars, 25 mm.
(B) RT-PCR analysis of the endodermal markers GATA4 and extraembyonic endodermal markers Sox7 during differentiation. Lane C, positive control,
RNA isolated from embryos and yolk sacs at 9,5 dpc. Amplified HPRT is shown as a positive control. (C) qRT-PCR for Pdx1 in wt and G6pdD ES cells at
13 days after treatment with Indolactam V from day 8 during differentiation. Values are means 6 SD (n=2). *P,0.05; **P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0029321.g002
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PLoS ONE | www.plosone.org 5 January 2012 | Volume 7 | Issue 1 | e29321Figure 3. Mechanism inducing endodermal cell differentiation. (A) RT-PCR of different lineage-specific marker genes in wt and G6pdD ES cells
in presence of a lower oxygen concentration (5%) and in normal culture conditions (20%). (B) RT-PCR of different lineage-specific markers in
differentiated wt E14 and Pgd+/2 ES cells at 8, 10 and 13 days of neural differentiation. (C) Double immunostaining Sox17/bIII-tubulin/DAPI of cells at
10 days of differentiation showed areas of immunoreactive cells for Sox17 only in Pgd+/2 ES cells. Scale bars, 75 mm. (D) qRT-PCR for Sox17 and
Pentose Phosphate Pathway and Endoderm
PLoS ONE | www.plosone.org 6 January 2012 | Volume 7 | Issue 1 | e29321PPP are among the most prominently induced by mTOR [6].
Inhibition of mTOR or simultaneous inactivation of c- and N-Myc
induce endodermal differentiation [4], [5]. Our results raise the
possibility that Myc and mTOR can repress endodermal
differentiation activating the PPP.
The data described will help direct experiments aimed at ES cell
differentiation into therapeutically relevant endodermal deriva-
tives.
Materials and Methods
ES cell culture
AK7 (wt), E14 Tg2A (MMRRC; wt E14), G6pdD, G6pdD
pG6pd
and Pgd+/2 (MMRRC Strain ID: 081091) ES cell lines were
maintained in an undifferentiated state by culturing them on a
mitomycin-C-inactivated fibroblast monolayer in presence of
leukemia-inhibiting factor (LIF) [30]. Under these conditions the
cell population remained undifferentiated, as determined by visual
inspection under phase-contrast microscopy.
In vitro differentiation
In vitro differentiation was performed according to Fico et al.
(2008) [13]. Briefly, at 48h before inducing differentiation wt AK7,
wt E14, G6pdD, G6pdD
pG6pd and Pgd+/2 ES cells were seeded on
gelatin-coated plates. At day 0, ES cells were dissociated in a
single-cell suspension and 1500 cells/cm
2 were plated on gelatin-
coated plates. The culture medium was replaced daily during
differentiation process. Culture medium for neuronal differentia-
tion (serum-free Knockout Serum Replacement (KSR)-supple-
mented medium) contained knockout Dulbecco minimal essential
medium supplemented with 15% KSR (Invitrogen), 2 mM
glutamine, 100 U/ml penicillin/streptomycin, and 0.1 mM b-
mercaptoethanol.
Endoderm differentiation was performed adding 1.5 g/l of D-(-)-
ribose in the differentiation medium. Addition of higher concen-
tration of D-(-)-ribose during the differentiation induced cell death,
lower concentration had no effect on endodermal differentiation.
To block the PPP we added DHEA and 6AN, at 100 mM and
10 mM final concentration respectively, in the differentiation
medium starting from the plating and carrying on for the entire
duration of the experiment.
RNA isolation and RT-PCR
Total RNA was isolated through PerfectPure RNA Cultured
Cell kit (5 PRIME). Reverse transcription-PCR (RT-PCR) was
performed with the Perkin-Elmer RT-PCR kit, as recommended
by the manufacturer. cDNA was amplified by PCR. The number
of cycles was chosen to select PCR conditions on the linear portion
of the reaction curve to avoid the saturation effects of PCR.
Sequence of specific primers, number of cycles, annealing
temperature, and the length of the amplified products have been
reported in Table S1.
Real-time RT-PCR
First-strand cDNA was synthesized from 500 ng of total RNA
using oligo-dT primers, random hexamers and SuperScript II
(Invitrogen). Real-time RT-PCR analysis was performed on
Biorad CFX 96 Real time System using the SYBR Green PCR
Master Mix (Biorad). The PCR reaction consists of 10 ml of SYBR
Green PCR Master Mix, 120 ng of forward and reverse primers,
and 4 ml of 1:30 diluted template cDNA in a total volume of 25 ml
and 40 cycles of amplification (95uC1 0s ;6 2 uC3 0s ;7 2 uC 10 s).
Primer specificity was determined by melting curve analysis and
standard curves were generated to check primer efficiency. The
relative expression of each gene was normalized against GAPDH.
GATA4 forward 59-CACTATGGGCACAGCAGCTCC-39,
GATA4 reverse 59-TTGGAGCTGGCCTGCGATGTC-39;
Sox17 forward 59-GGAGGGTCACCACTGCTTTA-39,
Sox17 reverse 59-AGATGTCTGGAGGTGCTGCT-39;
Pdx1 forward 59-TCACGCGTGGAAAGGCCAGT-39,
Pdx1 reverse 59-GTGTAGGCAGTACGGGTCCT-39;
GAPDH forward 59-TCTTCTGGGTGGCAGTGATG-39,
GAPDH reverse 59-TGCACCACCAACTGCTTAGC-39;
Three independent PCR reactions were performed for any
analyzed gene. Data were represented as mean 6 SD of at least
two independent experiments. Differences between control values
and experimental values were compared by Student’s t test.
Immunocytochemistry
Cells were fixed in 4% paraformaldehyde and 16phosphate-
buffer saline (PBS) at room temperature for 30 min. Following
fixation, samples were washed three times with 16 PBS for
5 min and then incubated with 10% normal goat serum (Dako
Cytomation, Glostrup, Denmark, http://dakocytomation.com)
and 0.1% triton X-100 in 16 PBS for 15 min at room
temperature. The cells were then washed three times in
16 PBS for 5 min and incubated with primary antibodies
(monoclonal anti bIII-tubulin, 1:400, Sigma-Aldrich; polyclonal
anti-GFAP, 1:300, Dako Cytomation) in 10% normal goat
serum and 16PBS. For antibody anti-Sox17 and anti-GATA4
after fixation the cells were permeabilized with 0.5% triton X-
100 in 16PBS for 5 min, blocked with 0.1% Triton, 10% BSA
and 16PBS for 1 hr and incubated with primary antibody (goat
polyclonal anti-Sox17, 1:20, R&D; goat polyclonal anti-
GATA4, 1:100, Santa Cruz Biotecnology Inc.) in 0.1% triton,
10% BSA in 16 PBS at 4uC overnight. Following primary
antibody incubation, cells were rinsed three times in 16 PBS
and further incubated with secondary antibodies: either anti-
mouse IgG FITC-conjugated (1:400; Molecular Probe) or anti-
rabbit IgG FITC-conjugated (1:200; Santa Cruz Biotechnology)
in 10% normal goat serum and 16PBS in for 30 min at room
temperature; anti-goat Alexa Fluor 594 (1:400; Invitrogen) in
0.1% triton, 0,1% BSA for 30 min at room temperature.
Finally, samples were washed three times in 16 PBS and
counterstained with 49,6 9-diamido-2-phenylindole (DAPI,
250 ng/ml; Sigma-Aldrich). Labelling was detected by fluores-
cent illumination using an inverted microscope (DMI 6000B,
Leica Microsystems); images were acquired on a DCF 360 FX
B/W camera (Leica).
Western Blot Analysis
Cells were lysed in 16RIPA lysis buffer in presence of protease
inhibitor mixture (Roche)/1% phosphatase inhibitor mixture
(Roche). Proteins were separated by 10% Tris-Glycine SDS/
PAGE (Bio-rad) under denaturing conditions and transferred to a
PVDF membrane. After blocking with 5% milk in 16PBS/0.1%
Triton X, the membrane was incubated with antibodies against
phospho-Smad2 (1:1000, Cell Signaling), Cripto (1:1000), Olig2
(1:1000, Dana Faber Cancer Institute), PARP (1:1000, New
England BioLabs) or b-actin (1:1000 Cell Signaling) overnight at
GATA4 in wt and G6pdD ES cells at day 10 after treatment with D-(-)-ribose during neural differentiation. Values are means 6 SD (n=3). *P,0.05;
**P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0029321.g003
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PLoS ONE | www.plosone.org 7 January 2012 | Volume 7 | Issue 1 | e29321Figure 4. Inhibitors of the PPP induce endodermal differentiation. (A) Double immunostaining Sox17/bIII-tubulin/DAPI of cells at 10 days of
differentiation showed areas of immunoreactive cells for Sox17 in wt ES cells differentiated in presence of DHEA or 6AN. Scale bars, 50 mm. (B) qRT-
PCR for Sox17 and GATA4 in wt ES cells at day 10 after treatment with DHEA or 6AN during neural differentiation. Values are means 6 SD (n=3).
*P,0.05; **P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0029321.g004
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mouse/rabbit peroxidase-conjugated secondary antibody (1:1000,
Cell Signaling) at room temperature for 1 hr, and developed by
ECL plus (Amersham).
Measurement of
14CO2 production
14CO2 produced by PPP or Glycolysis was determined as
previously described [10]. Differences between control values and
experimental values were compared by Student’s t test.
Measurement of ROS generation
ROS were detected using the fluorescent dye 29,79-dichloro-
fluorescein diacetate (DCFDA), (Molecular Probes, Eugene, OR)
as previously described [31]. Differences between control values
and experimental values were compared by Student’s t test.
Furosine Analysis
D-(-)-ribose treated and untreated G6pdD ES cells at day 13 of
differentiation were lysed in water (32 mg/ml) and hydrolyzed in 8N
hydrochloric acid (HCl) for 23 hr at 110uC. The hydrolysates were
filtered through a 0.45 mm Whatman filter paper. A 0.5 mL aliquot
of the filtered hydrolysate was purified by a C18 cartridge from
which furosine was eluted by 3 mL of 3N HCl and 20 mL of the
mixture was injected into the HPLC. Furosine was determined by
ion-pair RP-HPLC as previously described [32]. The separation of
furosine was performed in a C8 column (25064.6 mm i.d.) (Alltech
furosine- dedicated) (Alltech Associates, Laarne, Belgium).
Supporting Information
Figure S1 Evidence that GATA4+ and Sox17+ cells,
formed during G6pdD ES cells differentiation, are
endodermal precursors. (A) Double immunostaining
GFAP/GATA4 of cells at 13 days of differentiation show absence
of co-localization between the two markers, indicating that
GATA4 positive cells are not astrocytes. (B) Double immuno-
staining bIII-tubulin/GATA4 of cells at 13 days of differentiation
show absence of co-localization between the two markers,
indicating that GATA4 positive cells are not neurons. (C) Western
blot analysis with anti-Olig2 and anti-Actin antibodies performed
on protein extracts from wt and G6pdD undifferentiated ES cells
(day 0) and at 10 days of neural differentiation. Actin was analyzed
as loading control. (D–E) qRT-PCR for Nodal and Cripto in wt
and G6pdD ES cells during differentiation. Values are means 6 SD
(n=2). *P,0.05; **P,0.01; ***P,0.001.
(TIF)
Figure S2 Differentiation in antioxidant conditions. (A)
Reduced amount of reactive oxygen species (ROS) is detected in
G6pdD differentiated ES cells in presence of 5% oxygen compared
with the ones cultured at 20% oxygen concentration. Values are
means 6 SD (n=2). *P,0.05; **P,0.01; ***P,0.001. (B) RT-
PCR of different lineage-specific markers in wt and G6pdD ES cells
differentiated for 10 days in presence of NAC.
(TIF)
Figure S3 Characteritazation of heterozygous knockout
Pgd ES cells (Pgd+/2). (A) RT-PCR analysis of Pgd mRNA
level in undifferentiated Pgd+/2 and wt E14 ES cells. Amplified
HPRT is shown as a positive control. (B) Activity of the PPP
determined by [1-
14C] glucose and the cmp/mg of protein of
14CO2 released in wt and Pgd+/2 ES cells. Values are means 6
SD (n=3). *P,0.05; **P,0.01; ***P,0.001. (C) wt, G6pdD,w t
E14, and Pgd+/2 undifferentiated ES cells were incubated with 0,
300 or 800 mM of Diamide, a thiol-oxidizing agent, for 30 min.
After 8 hr, total proteins were extracted and separated on SDS-
PAGE, and their respective content in cleaved PARP was
analyzed by Western blotting. (D–E) Double immunostaining
GFAP/GATA4 of wt E14 and Pgd+/2 ES cells at 13 days of
differentiation show absence of co-localization between the two
markers, indicating that GATA4 positive cells are not astrocytes.
(F) qRT-PCR for GATA4 in wt E14 and Pgd+/2 ES cells during
neural differentiation. Values are means 6 SD (n=3). *P,0.05;
**P,0.01; ***P,0.001. (G) qRT-PCR for Sox17 in G6pdD ES
cells at day 10 during neural differentiation in presence of different
sugars: D-ribose (D-rib), L-ribose (L-rib), L-arabinose (L-arab) and
sucrose (Sucr) at 10 mM final concentration. Values are means 6
SD (n=3). *P,0.05; **P,0.01; ***P,0.001.
(TIF)
Figure S4 Characterization of ES cells treated with
DHEA or 6AN. (A) Activity of pentose phosphate pathway
determined by 1-
14C glucose and the cmp/mg of protein of
14CO2
released in wt ES cells treated with DHEA or 6AN. Values are
means 6 SD (n=3). *P,0.05; **P,0.01; ***P,0.001. (B) ES cells
treated with DHEA and 6AN were incubated with 300 mMo f
Diamide for 30 min. After 8 hr, total proteins were extracted and
separated on SDS-PAGE, and their respective content in cleaved
PARP was analyzed by Western blotting. Actin was analyzed as
loading control.
(TIF)
Table S1 Primers used and PCR conditions.
(DOC)
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